# EDGAR Filing Document

**Accession Number:** 0001008586
**File Stem:** 0001437749-25-021739
**Filing Date:** 2025-7
**Character Count:** 28846
**Document Hash:** 5f950e0e7235df1f1492e479690cfaca
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-021739.hdr.sgml**: 20250701

**ACCESSION NUMBER**: 0001437749-25-021739

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20250626

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250701

**DATE AS OF CHANGE**: 20250701

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STREAMLINE HEALTH SOLUTIONS INC.
- **CENTRAL INDEX KEY:** 0001008586
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 311455414
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0131

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-28132
- **FILM NUMBER:** 251096275

**BUSINESS ADDRESS:**
- **STREET 1:** 2400 OLD MILTON PARKWAY
- **STREET 2:** BOX 1353
- **CITY:** ALPHARETTA
- **STATE:** GA
- **ZIP:** 30009
- **BUSINESS PHONE:** 888-997-8732

**MAIL ADDRESS:**
- **STREET 1:** 2400 OLD MILTON PARKWAY
- **STREET 2:** BOX 1353
- **CITY:** ALPHARETTA
- **STATE:** GA
- **ZIP:** 30009

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** STREEAMLINE HEALTH SOLUTIONS INC.
- **DATE OF NAME CHANGE:** 20060809

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LANVISION SYSTEMS INC
- **DATE OF NAME CHANGE:** 19960220

?xml version='1.0' encoding='ASCII'? strm20250701_8k.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

------

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of The**

**Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **June 26, 2025**

**Streamline Health Solutions, Inc.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **0-28132** | **31-1455414** |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |

---

**2400 Old Milton Pkwy., Box 1353**

**Alpharetta, GA 30009**

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: **(888) 997-8732**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| **Common Stock, $0.01 par value** | **STRM** | **Nasdaq Capital Market** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 1.01.**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Entry into a Material Definitive Agreement.**

The information set forth in Item 2.03 of this Current Report on Form 8-K is incorporated by reference into this Item 1.01.

**Item 2.03.**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.**

On June 26, 2025, Streamline Health Solutions, Inc. (the "Company") and certain of its subsidiaries entered into a Seventh Modification (the "Seventh Modification") to Second Amended and Restated Loan and Security Agreement (as amended, restated, supplemented and otherwise modified from time to time, the "Loan and Security Agreement") with Western Alliance Bank ("WAB"). The Seventh Modification amended certain financial covenants in the Loan and Security Agreement, including updating the maximum ARR net leverage ratio and minimum adjusted EBITDA thresholds.

The Seventh Modification also requires the Company to pay certain fees to WAB in the event advances to the Company or its subsidiaries under the Loan and Security Agreement exceed $2,000,000. The foregoing fees, if any, will be due and payable on the earlier of (i) August 26, 2026, and (ii) the date on which the Company repays in full all obligations due to WAB under the Loan and Security Agreement.

The foregoing description of the terms of the Seventh Modification does not purport to be complete and is qualified in its entirety by reference to the full text of the Seventh Modification, which is attached hereto as Exhibit 10.1 and incorporated herein by reference.

**Item 5.02.**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Departure for Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

***Transaction Bonuses***

As previously announced, on May 29, 2025, the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") with Mist Holding Co., a Delaware corporation and the parent company of Hayes Management Consulting LLC d/b/a MDaudit ("Parent"), and MD BE Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which, upon the terms and subject to the conditions set forth therein, Merger Sub shall merge with and into the Company, with the Company continuing as the surviving corporation and becoming a wholly owned subsidiary of Parent (the "Merger").

On June 27, 2025, in connection with the signing of the Merger Agreement, the board of directors of the Company approved the grant of transaction cash bonuses (the "Transaction Bonuses") to certain executive officers of the Company, including a cash bonus of $75,000 to Benjamin L. Stilwill and $45,000 to Bryant J. Reeves, III. The Transaction Bonuses are contingent upon, and subject to each individual's service through, the closing of the Merger and will be payable on the Company's next regular payroll following the closing of the Merger.

------

**Item 9.01**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Financial Statements and Exhibits.**

*(d) Exhibits.*

---

| | |
|:---|:---|
| **EXHIBIT**<br> **NUMBER** | **DESCRIPTION** |
| 10.1\* | [Seventh Modification to Second Amended and Restated Loan and Security Agreement, dated June 26, 2025, by and between Streamline Health Solutions, Inc. and certain of its subsidiaries party thereto, and Western Alliance Bank.](ex_835540.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\* Filed herewith

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **STREAMLINE HEALTH SOLUTIONS, INC.** | **STREAMLINE HEALTH SOLUTIONS, INC.** |
| Date: July 1, 2025 | By: | /s/ Bryant J. Reeves, III |
|  |  | Bryant J. Reeves, III |
|  |  | Chief Financial Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**SEVENTH MODIFICATION** 

**TO**

**SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT**

THIS SEVENTH MODIFICATION TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this "<u>Modification</u>") is entered into as of June 26, 2025 by and among STREAMLINE HEALTH SOLUTIONS, INC., a Delaware corporation ("<u>Streamline</u>"), STREAMLINE HEALTH, LLC, a Delaware limited liability company (f/k/a STREAMLINE HEALTH, INC., an Ohio corporation) ("<u>Streamline Health</u>"), STREAMLINE PAY & BENEFITS, LLC, a Delaware limited liability company ("<u>Streamline Pay</u>"), AVELEAD CONSULTING, LLC, a Georgia limited liability company ("<u>Avelead Consulting</u>"), STREAMLINE CONSULTING SOLUTIONS, LLC, a Delaware limited liability company ("<u>Streamline Consulting</u>" and, together with Streamline, Streamline Health, Streamline Pay, Avelead Consulting and any other Person who, from time to time, becomes a Borrower under the Loan Agreement (as defined below), collectively, the "<u>Borrowers</u>" and each individually, a "<u>Borrower</u>") and WESTERN ALLIANCE BANK, an Arizona corporation ("<u>Bank</u>").

**RECITALS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. Bank and Borrowers have previously entered into that certain Second Amended and Restated Loan and Security Agreement, dated as of August 26, 2021 (as amended, restated, supplemented and otherwise modified from time to time, the "<u>Loan Agreement</u>"), pursuant to which Bank has made certain loans and financial accommodations available to Borrowers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B. Bank and Borrowers now wish to modify the Loan Agreement on the terms and conditions set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C. Borrowers are entering into this Modification with the understanding and agreement that, except as specifically provided herein, none of Bank's rights or remedies as set forth in the Loan Agreement or any other Loan Document is being waived or modified by the terms of this Modification.

**AGREEMENT**

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. <u>MODIFICATIONS</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Additional Definitions</u>. Section 1.1 of the Loan Agreement is hereby amended to add the following new definitions in the appropriate alphabetical order:

""<u>Seventh Modification Closing Date</u>" means June 26, 2025."

""<u>Temporary Increase Period</u>" means the period commencing on the Seventh Modification Closing Date through and including August 28, 2025."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Revolving Line</u>. The definition of "Revolving Line" set forth in Section 1.1 of the Loan Agreement is hereby amended and restated in its entirety to read as follows:

""<u>Revolving Line</u>" means a credit extension of up to (a) during the Temporary Increase Period, Three Million Dollars ($3,000,000) and (b) on August 29, 2025 and at all times thereafter, Two Million Dollars ($2,000,000)."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Success Fee</u>. Section 2.4(d) of the Loan Agreement is hereby amended and restated in its entirety to read as follows:

"(d) **Success Fees**. On the earlier of (i) the Term Loan Maturity Date and (ii) the date on which Borrowers repay in full all Obligations due to Bank under this Agreement, a success fee (the "<u>Success Fee</u>") equal to the sum of (A) $300,000, <u>plus</u> (B) ten percent (10%) multiplied by the greatest amount by which the outstanding Advances exceed $2,000,000 during the Temporary Increase Period, which Success Fee (1) under the immediately foregoing clause (A) shall be fully earned as of the Sixth Modification Closing Date and (2) under the immediately foregoing clause (B) shall be fully earned as of each date such Advances exceed $2,000,000 and, in each case, payable on the earlier of such dates referenced in this clause (d)."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Maximum ARR Net Leverage Ratio</u>. Section 6.9(b) of the Loan Agreement is hereby amended and restated in its entirety to read as follows:

"(b) **Maximum ARR Net Leverage Ratio**. Commencing with the month ended February 28, 2025, Borrowers' ARR Net Leverage Ratio, measured on a monthly basis as of the last day of each month, shall not be greater than the amount set forth under the heading "Maximum ARR Net Leverage Ratio" as of, and for each of the dates appearing adjacent to such "Maximum ARR Net Leverage Ratio".

---

| | |
|:---|:---|
| **<u>Month Ending</u>** | **<u>Maximum ARR Net Leverage Ratio</u>** |
| May 31, 2025 and on the last day of each month thereafter | 0.67 to 1.00 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Minimum Adjusted EBITDA</u>. Section 6.9(e) of the Loan Agreement is hereby amended and restated in its entirety to read as follows:

"(e) **Minimum Adjusted EBITDA.** Commencing with the month ended February 28, 2025, Borrowers shall maintain Adjusted EBITDA, measured on a monthly basis as of the last day of each month, in an amount not less than the amounts (or, in the case of amounts set forth in parentheses, no worse than the amounts) set forth under the heading "Minimum Adjusted EBITDA" as of, and for each of the dates appearing adjacent to such "Minimum Adjusted EBITDA".

---

| | |
|:---|:---|
| **<u>Month Ending</u>** | **<u>Minimum Adjusted EBITDA</u>** |
| May 31, 2025 | ($250000) |
| June 30, 2025 | ($250000)" |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Compliance Certificate</u>. **Exhibit B** to the Loan Agreement is hereby deleted in its entirety and replaced with **Exhibit B** attached hereto.

2. <u>NO DEFENSES OF BORROWER/GENERAL</u> <u>RELEASE</u>. Each Borrower agrees that, as of this date, it has no defenses against the obligations to pay any amounts under the Indebtedness. Each Borrower acknowledges that Bank would not enter into this Modification without Borrower's assurance that it has no claims against Bank or any of Bank's officers, directors, employees or agents. Except for any claims or obligations arising after the date of this Modification, each Borrower releases Bank, and each of Bank's officers, directors and employees from any known or unknown claims that such Borrower now has against Bank of any nature, including any claims that such Borrower, its successors, counsel, and advisors may in the future discover they would have now had if they had known facts not now known to them, whether founded in contract, in tort or pursuant to any other theory of liability, including but not limited to any claims arising out of or related to the Loan Agreement or the transactions contemplated thereby. Each Borrower acknowledges and agrees that they have been informed by their attorneys and advisors of, and are familiar with, and do hereby expressly waive, the provisions of Section 1542 of the California Civil Code, and any similar statute, code, law, or regulation of any state or the United States, to the full extent that they may waive such rights and benefits. Civil Code section 1542 provides:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR A BORROWER DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.

**The provisions, waivers and releases set forth in this section are binding upon each Borrower and its shareholders, agents, employees, assigns and successors in interest. The provisions, waivers and releases of this section shall inure to the benefit of Bank and its agents, employees, officers, directors, assigns and successors in interest. The provisions of this section shall survive payment in full of the Obligations, full performance of all the terms of this Modification and the Loan Agreement, and/or Bank**'**s actions to exercise any remedy available under the Loan Agreement or otherwise.**

3. <u>CONTINUING VALIDITY</u>. Borrowers understand and agree that in modifying the existing Indebtedness, Bank is relying upon Borrowers' representations and warranties set forth in this Modification and the reaffirmation of Borrowers' performance obligations under the Loan Documents, subject to the modifications set forth herein. Except as expressly modified pursuant to this Modification, the terms of the Loan Documents remain unchanged and in full force and effect. Bank's agreement to modifications to the existing Indebtedness pursuant to this Modification in no way shall obligate Bank to make any future modifications to the Indebtedness. Nothing in this Modification shall constitute a satisfaction of the Indebtedness. It is the intention of Bank and Borrowers to retain as liable parties all makers and endorsers of Loan Documents, unless the party is expressly released by Bank in writing. No maker, endorser, or guarantor will be released by virtue of this Modification. The terms of this paragraph apply not only to this Modification, but also to any subsequent modification agreements.

4. <u>EFFECTIVENESS OF THIS MODIFICATION</u>. This Modification, and the waivers provided for herein, shall become effective upon the satisfaction, as determined by Bank, of the following conditions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Modification</u>. Bank shall have received this Modification fully executed in a sufficient number of counterparts for distribution to all parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Representations and Warranties</u>. The representations and warranties set forth herein and in the Loan Agreement are true and correct in all material respects (except for such representations and warranties qualified by materiality, which shall be true and correct in all respects).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Other Required Documentation.</u> All other documents and legal matters in connection with the transactions contemplated by this Modification shall have been delivered or executed or recorded, as required by Bank.

Bank shall provide prompt written notice (e-mail to suffice) to Borrowers confirming the satisfaction of the conditions in this Section 5 and the effectiveness of this Modification, which confirmation shall be binding on Bank.

5. <u>CHOICE OF LAW AND VENUE; JURY TRIAL WAIVER; REFERENCE PROVISION</u>. This Modification constitutes a "Loan Document" as defined and set forth in the Loan Agreement, and is subject to Sections 11 and 12 of the Loan Agreement, which are incorporated by reference herein.

6. <u>NOTICE OF FINAL AGREEMENT</u>. By signing this document each party represents and agrees that: (A) this written agreement represents the final agreement between the parties, (B) there are no unwritten oral agreements between the parties, and (C) this written agreement may not be contradicted by evidence of any prior, contemporaneous, or subsequent oral agreements or understandings of the parties.

7. <u>COUNTERPARTS; FACSIMILE SIGNATURES</u>. This Modification may be executed in any number of and by different parties hereto on separate counterparts, all of which, when so executed, shall be deemed an original, but all such counterparts shall constitute one and the same agreement. Any signature delivered by a party by facsimile or other similar form of electronic transmission shall be deemed to be an original signature hereto.

8. <u>RATIFICATION</u>. Borrowers hereby covenant and agree to comply with each and every term and condition set forth in the Loan Agreement, as amended hereby, and the other Loan Documents effective as of the date hereof, and hereby reaffirm their various obligations thereunder.

9. <u>INTEGRATION</u>. This Modification, together with the Loan Agreement and the other Loan Documents, incorporates all negotiations of the parties hereto with respect to the subject matter hereof and is the final expression and agreement of the parties hereto with respect to the subject matter hereof.

[Signature Page Follows]

------

<u>BORROWER</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**STREAMLINE HEALTH SOLUTIONS, INC.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Bryant J. Reeves, III</u><u> </u><u> </u><u> </u>

Name: Bryant J. Reeves, III

&nbsp;&nbsp;&nbsp;&nbsp;Title: Chief Financial Officer

**STREAMLINE HEALTH, LLC** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(F/K/A STREAMLINE HEALTH, INC.)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Bryant J. Reeves, III</u><u> </u><u> </u><u> </u>

Name: Bryant J. Reeves, III

&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Signatory

**STREAMLINE PAY & BENEFITS, LLC**

By: <u>/s/ Bryant J. Reeves, III</u><u> </u><u> </u><u> </u>

Name: Bryant J. Reeves, III

&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Signatory

**AVELEAD CONSULTING, LLC**

By: <u>/s/ Bryant J. Reeves, III</u><u> </u><u> </u><u> </u>

Name: Bryant J. Reeves, III

&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Signatory

**STREAMLINE CONSULTING SOLUTIONS, LLC**

By: <u>/s/ Bryant J. Reeves, III</u><u> </u><u> </u><u> </u>

Name: Bryant J. Reeves, III

&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Signatory

------

<u>BANK</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**WESTERN ALLIANCE BANK**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Steven Slaughter</u><u> </u><u> </u><u> </u><u> </u>

Name: Steven Slaughter

&nbsp;&nbsp;&nbsp;&nbsp;Title: Vice President

------

**EXHIBIT B**

**COMPLIANCE CERTIFICATE**

TO: WESTERN ALLIANCE BANK, an Arizona corporation

FROM: Streamline Health Solutions, Inc., a Delaware corporation and Streamline Health, Inc., an Ohio corporation, Streamline Pay & Benefits, LLC, a Delaware limited liability company, Avelead Consulting, LLC, Streamline Consulting Solutions, LLC

The undersigned authorized officer of Borrower hereby certifies that in accordance with the terms and conditions of the Amended and Restated Loan and Security Agreement between Borrower and Bank (the "Agreement"), (i) Borrower is in complete compliance for the period ending _______________ with all required covenants except as noted below and (ii) all representations and warranties of Borrower stated in the Agreement are true and correct as of the date hereof. Attached herewith are the required documents supporting the above certification. The Officer further certifies that these are prepared in accordance with Generally Accepted Accounting Principles (GAAP) and are consistently applied from one period to the next except as explained in an accompanying letter or footnotes.

**Please indicate compliance status by circling Yes/No under** "**Complies**" **column.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Reporting Covenant</u>** | **<u>Required</u>** | **<u>Required</u>** | **<u>Complies</u>** | **<u>Complies</u>** |
| Annual financial statements (CPA Audited) | FYE within 180 days | FYE within 180 days | Yes | No |
| Monthly financial statements and a Compliance Certificate | Monthly within 30 days | Monthly within 30 days | Yes | No |
| 10K and 10Q | (as applicable) | (as applicable) | Yes | No |
| Annual operating budget, sales projections and operating plans approved by board of directors | Annually no later than 30 days prior to the beginning of each fiscal year | Annually no later than 30 days prior to the beginning of each fiscal year | Yes | No |
| A/R & A/P Agings, Borrowing Base Certificate, Deferred Revenue Schedule and Monthly Recurring Revenue Report | Monthly within 30 days | Monthly within 30 days | Yes | No |
| A/R Audit | Initial and Annual | Initial and Annual | Yes | No |
| Deposit balances with Bank | $___________________ | $___________________ | Yes | No |
| Deposit balance outside Bank | $___________________ | $___________________ |  |  |
|  |  |  | Yes | No |
| **<u>Financial Covenant</u>** | **<u>Required</u>** | **<u>Actual</u>** | **<u>Complies</u>** | **<u>Complies</u>** |
| Maximum ARR Net Leverage Ratio | May 31, 2025, and on the last day of each month thereafter, 0.67 to 1.00. | ___ to 1.00 | Yes | No |
| Maximum Debt to Adjusted EBITDA Ratio | (a) July 31, 2025, 3.50 to 1.00, (b) October 31, 2025, 3.00 to 1.00, (c) January 31, 2026, 2.50 to 1.00 and (d) April 30, 2026 and on the last day of each quarter thereafter, 2.00 to 1.00 | ___ to 1.00 | Yes | No |
| Fixed Charge Coverage Ratio | July 31, 2025 and on the last day of each quarter thereafter, 1.20 to 1.00 | ___ to 1.00 | Yes | No |
| Minimum Adjusted EBITDA | (a) May 31, 2025, ($250000) and (b) June 30, 2025, ($250000). | $_____ | Yes | No |
| **<u>Intellectual Property Updates</u>**<br> Attached as Exhibit A is a listing of listing of any applications or registrations of intellectual property rights filed with the United States Patent and Trademark Office, including the date of such filing and the registration or application numbers, if any, since the date of the last such Compliance Certificate delivered to Bank.<br> **<u>Updates to Schedules</u>**<br> Attached as Exhibit A are updated Schedules updating any information set forth in such Schedules since the date of the last such Compliance Certificate delivered to Bank. | **<u>Intellectual Property Updates</u>**<br> Attached as Exhibit A is a listing of listing of any applications or registrations of intellectual property rights filed with the United States Patent and Trademark Office, including the date of such filing and the registration or application numbers, if any, since the date of the last such Compliance Certificate delivered to Bank.<br> **<u>Updates to Schedules</u>**<br> Attached as Exhibit A are updated Schedules updating any information set forth in such Schedules since the date of the last such Compliance Certificate delivered to Bank. | **<u>Intellectual Property Updates</u>**<br> Attached as Exhibit A is a listing of listing of any applications or registrations of intellectual property rights filed with the United States Patent and Trademark Office, including the date of such filing and the registration or application numbers, if any, since the date of the last such Compliance Certificate delivered to Bank.<br> **<u>Updates to Schedules</u>**<br> Attached as Exhibit A are updated Schedules updating any information set forth in such Schedules since the date of the last such Compliance Certificate delivered to Bank. |  |  |

---

---

| | | |
|:---|:---|:---|
| **Comments Regarding Exceptions:** See Attached. | **BANK USE ONLY** | **BANK USE ONLY** |
|  | Received by:<u> </u> | Received by:<u> </u> |
| Sincerely, | AUTHORIZED SIGNER | AUTHORIZED SIGNER |
|  | Date:<u> </u> | Date:<u> </u> |
| **<u>__________________________________________</u>** | Verified:<u> </u> | Verified:<u> </u> |
| SIGNATURE | AUTHORIZED SIGNER | AUTHORIZED SIGNER |
| **<u>_________________________________________</u>** | Date:<u> </u> | Date:<u> </u> |
| TITLE | | |
|  | Compliance Status | Yes No |
| <u>___________________________________________</u> | | |
| DATE | | |

---